Atlas Trials

Refractory Childhood Osteosarcoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Childhood Osteosarcoma

RecordFirmDate
Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial (NCT04539366)National Cancer Institute (NCI)2022-01-25
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) (NCT03210714)National Cancer Institute (NCI)2018-06-05

Track Refractory Childhood Osteosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.